litlas
Log inCreate account

Juan Rodés

Active 1980–2013

80
Papers
26,604
Citations
78
h-index
80
i10-index

Citations

Citations per year for Juan Rodés1979: 1 citations1980: 1 citations1981: 2 citations1982: 2 citations1983: 3 citations1984: 6 citations1985: 13 citations1986: 10 citations1987: 11 citations1988: 11 citations1989: 18 citations1990: 15 citations1991: 9 citations1992: 19 citations1993: 8 citations1994: 7 citations1995: 16 citations1996: 12 citations1997: 15 citations1998: 21 citations1999: 46 citations2000: 54 citations2001: 84 citations2002: 112 citations2003: 185 citations2004: 204 citations2005: 326 citations2006: 297 citations2007: 360 citations2008: 376 citations2009: 327 citations2010: 306 citations2011: 256 citations2012: 308 citations2013: 210 citations2014: 247 citations2015: 234 citations2016: 111 citations2017: 152 citations2018: 136 citations2019: 407 citations2020: 375 citations2021: 328 citations2022: 188 citations2023: 131 citations2024: 205 citations2025: 88 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,599 citing papers, 22.1% of this breakdownSpain: 694 citing papers, 9.6% of this breakdownItaly: 609 citing papers, 8.4% of this breakdownUnited Kingdom: 458 citing papers, 6.3% of this breakdownChina: 437 citing papers, 6% of this breakdownFrance: 417 citing papers, 5.7% of this breakdownGermany: 408 citing papers, 5.6% of this breakdownCanada: 289 citing papers, 4% of this breakdownJapan: 231 citing papers, 3.2% of this breakdownSouth Korea: 201 citing papers, 2.8% of this breakdownIndia: 137 citing papers, 1.9% of this breakdownSwitzerland: 136 citing papers, 1.9% of this breakdown
0%22.1%Other 22.5%

Institutions

Fields

  • Medicine90.8%
  • Biochemistry, Genetics and Molecular Biology4.8%
  • Nursing1.2%
  • Immunology and Microbiology1.1%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Neuroscience0.5%
  • Other1%

Topics

  • Liver Disease Diagnosis and Treatment16.7%
  • Liver Disease and Transplantation15.3%
  • Hepatocellular Carcinoma Treatment and Prognosis7.2%
  • Organ Transplantation Techniques and Outcomes6.2%
  • Hepatitis C virus research4%
  • Liver Diseases and Immunity3.6%
  • Other47%

Coauthors

All papers

Open in search
  1. Excellent Long-Term Survival in Patients With Primary Biliary Cirrhosis and Biochemical Response to Ursodeoxycholic Acid

    Authors: Albert Parés, Llorenç Caballería, Juan Rodés - Gastroenterology 2006 cited by 758

  2. Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

    Authors: Jordi Bruix, Morris Sherman, Josep M. Llovet, Michel Beaugrand, Riccardo Lencioni, Andrew K. Burroughs, Erik Christensen, Luigi Pagliaro, Massimo Colombo, Juan Rodés - Journal of Hepatology 2001 cited by 4,080

  3. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

    Authors: Xavier Forns, Sergi Ampurdanés, Josep M. Llovet, John Álvaro Niño Aponte, Llorenç Quintó, Eva Martínez‐Bauer, Miquel Bruguera, José María Sánchez-Tapias, Juan Rodés - Hepatology 2002 cited by 1,110

  4. Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized Study

    Authors: Marta Martín–Llahí, M.N. Pepin, Mónica Guevara, Fernando Dı́az, Aldo Torre, Alberto Monescillo, Germán Soriano, Carlos Terra, Emilio Fábrega, Vicente Arroyo, Juan Rodés, Pere Ginès - Gastroenterology 2008 cited by 594

  5. Hemodynamic Response to Pharmacological Treatment of Portal Hypertension and Long–Term Prognosis of Cirrhosis

    Authors: Juan G. Abraldeṣ, Ilaria Tarantino, Juan Turnes, Juan Carlos Garcia-Pagan, Juan Rodés, Jaime Bosch - Hepatology 2003 cited by 532

  6. Prognostic significance of hepatic encephalopathy in patients with cirrhosis

    Authors: Javier Bustamante, Antoni Rimola, Pere‐Joan Ventura, Miquel Navasa, Isabel Cirera, Virginia Reggiardo, Juan Rodés - Journal of Hepatology 1999 cited by 563

  7. Bacterial translocation of enteric organisms in patients with cirrhosis

    Authors: Isabel Cirera, Tilman Bauer, Miguel Navasa, Jordi Vilà, Luis Grande, Pilar Taurá, Josep Fuster, Juan Carlos García‐Valdecasas, Antonio M. Lacy, Marı́a Jesús Suárez, A. Rimola, Juan Rodés - Journal of Hepatology 2001 cited by 430

  8. Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II

    Authors: Ramón Bataller, Pau Sancho‐Bru, Pere Ginès, José M. Lora, Amal Al‐Garawi, Manel Solé, Jordi Colmenero, Josep M. Nicolás, Wladimiro Jiménez, Nadine Weich, Jose‐Carlos Gutierrez‐Ramos, Vicente Arroyo, Juan Rodés - Gastroenterology 2003 cited by 357

  9. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis

    Authors: Pere Ginès, Juan Uríz, B. Calahorra, Guadalupe García–Tsao, Patrick S. Kamath, L Ruíz del Arbol, Ramón Planas, Jaime Bosch, Vicente Arroyo, Juan Rodés - Gastroenterology 2002 cited by 541

  10. Prognostic Importance of the Cause of Renal Failure in Patients With Cirrhosis

    Authors: Marta Martín–Llahí, Mónica Guevara, Aldo Torre, Cláudia Fagundes, Tea Restuccia, Rosa Gilabert, Elsa Solà, Gustavo Pereira, M. Marinelli, Marco Pavesi, Javier Fernández, Juan Rodés, Vicente Arroyo, Pere Ginès - Gastroenterology 2010 cited by 372

  11. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial

    Authors: Albert Parés, Llorenç Caballería, Juan Rodés, Miquel Bruguera, Luı́s Rodrigo, Antonio García-Plaza, Juan Berenguer, Dolores Rodrı́guez-Martı́nez, J M Mercader, R Velicia - Journal of Hepatology 2000 cited by 273

  12. Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S‐hydroxy‐DHA

    Authors: Ana González‐Périz, Anna Planagumà, Karsten Gronert, Rosa Miquel, Marta López‐Parra, Esther Titos, Raquel Horrillo, Natàlia Ferré, R. Deulofeu, Vicente Arroyo, Juan Rodés, Joan Clària, Ana González‐Périz, Anna Planagumà, Karsten Gronert, Rosa Miquel, Marta López‐Parra, Esther Titos, Raquel Horrillo, Natàlia Ferré, R. Deulofeu, Vicente Arroyo, Juan Rodés, Joan Clària - The FASEB Journal 2006 cited by 225

  13. Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis

    Authors: Javier Fernández, Miquel Navasa, J Gómez, Jordi Colmenero, Jordi Vilà, Vicente Arroyo, Juan Rodés - Hepatology 2002 cited by 959

  14. Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis

    Authors: Carmen Zafra, Juan G. Abraldeṣ, Juan Turnés, Annalisa Berzigotti, Mercedes Fernández, Juan Carlos García‐Pagán, Juan Rodés, Jaime Bosch - Gastroenterology 2004 cited by 291

  15. Management of Cirrhosis and Ascites

    Authors: Pere Ginès, Andrés Cárdenas, Vicente Arroyo, Juan Rodés - New England Journal of Medicine 2004 cited by 774

  16. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage

    Authors: Roberto J. Groszmann, Jackie Bosch, Norman D. Grace, Harold O. Conn, Guadalupe García–Tsao, Miguel Navasa, Jeanne Alberts, Juan Rodés, Rosemarie Fischer, Max Bermann, Stephen Rofe, Michael J. Patrick, Emanuel Lerner - Gastroenterology 1990 cited by 727

  17. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study

    Authors: Rolando Ortega, Pere Ginès, Juan Uríz, Andrés Cárdenas, B. Calahorra, Dara De Las Heras, Mónica Guevara, Ramón Bataller, Wladimiro Jiménez, Vicente Arroyo, Juan Rodés - Hepatology 2002 cited by 590

  18. Prognostic value of early measurements of portal pressure in acute variceal bleeding

    Authors: Eduardo Moitinho, Àngels Escorsell, Juan Carlos Bandi, Joan–Manuel Salmerón, Joan–Carles García–Pagán, Juan Rodés, Jaime Bosch - Gastroenterology 1999 cited by 490

  19. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems

    Authors: Mónica Guevara, Pere Ginès, Juan Carlos Bandi, Rosa Gilabert, Pau Sort, Wladimiro Jiménez, Juan Carlos García‐Pagán, Jaume Bosch, Vicente Arroyo, Juan Rodés - Hepatology 1998 cited by 425

  20. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma

    Authors: Matías A. Ávila, Carmen Berasain, Luís Torres, Antonio Martín‐Duce, Fernando J. Corrales, Heping Yang, Jesús Prìeto, Shelly C. Lu, Juan Caballería, Juan Rodés, José M. Mato - Journal of Hepatology 2000 cited by 340

  21. Human Hepatic Stellate Cells Show Features of Antigen–Presenting Cells and Stimulate Lymphocyte Proliferation

    Authors: Odette Viñas, Ramón Bataller, Pau Sancho‐Bru, Pere Ginès, Cristina Berenguer, Carlos Enrich, Josep M. Nicolás, Guadalupe Ercilla, Teresa Gallart, Jordi Vives, Vicente Arroyo, Juan Rodés - Hepatology 2003 cited by 179

  22. Hepatorenal syndrome

    Authors: Pere Ginès, Mónica Guevara, Vicente Arroyo, Juan Rodés - The Lancet 2003 cited by 515

  23. MELD score and clinical type predict prognosis in hepatorenal syndrome

    Authors: Carlo Alessandria, Osman Özdoğan, Mónica Guevara, Tea Restuccia, Wladimiro Jiménez, Vicente Arroyo, Juan Rodés, Pere Ginès - Hepatology 2005 cited by 373

  24. Angiotensin II induces contraction and proliferation of human hepatic stellate cells

    Authors: Ramón Bataller, Pere Ginès, Josep M. Nicolás, Marı́a Nieves Görbig, Eva García-Ramallo, Xavier Gasull, Jaime Bosch, Vicente Arroyo, Juan Rodés - Gastroenterology 2000 cited by 495